Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biotech Stock Mailbag Extra: MannKind's Afrezza Panel Setup
TheStreet.com
Thursday, March 6, 2014 - 10:28am
tags:
advisory panels, FDA, Afrezza, diabetes, MannKind, inhaled insulin
US fears for patents on next-generation drugs in India
Yahoo/Reuters
Thursday, March 6, 2014 - 10:22am
tags:
patents, India
Can Diabetes Treatments Replace Patent Losses At Eli Lilly & Co?
Motley Fool
Thursday, March 6, 2014 - 10:17am
tags:
Eli Lilly, diabetes, patents, dulaglutide, GLP-1 agonist, Novo Nordisk, AstraZeneca, GSK, JNJ
Titan Looking Attractive After Positive FDA Meeting
Seeking Alpha
Thursday, March 6, 2014 - 10:12am
tags:
Titan Pharmaceuticals, FDA, Probuphine, opioid addiction
Biostar Pharmaceuticals to develop liver cancer drug with Chinese university
Yahoo/Fly on the Wall
Thursday, March 6, 2014 - 10:10am
tags:
Biostar Pharmaceuticals, liver cancer
Osiris Misses on Q4 Earnings
Yahoo/Zacks.com
Thursday, March 6, 2014 - 10:02am
tags:
Osiris Therapeutics, earnings
Endo Health's Aveed testosterone injection approved by FDA
Yahoo/Fly on the Wall
Thursday, March 6, 2014 - 9:58am
tags:
Aveed, Endo Health Solutions, FDA, testosterone
Sun Pharma says seeks to enter Japan generics market
Yahoo/Reuters
Thursday, March 6, 2014 - 9:56am
tags:
India, Japan, Sun Pharma, generics
Technology companies eye health market
FT.com
Thursday, March 6, 2014 - 9:42am
tags:
Google, eye health, Apple, Samsung
Zogenix Reports Q4 Earnings; Shares Soar 5%
Yahoo/Benzinga
Thursday, March 6, 2014 - 9:40am
tags:
earnings, Zogenix
Stryker Continues Acquisition Spree but Shares Fall
Yahoo/Zacks.com
Thursday, March 6, 2014 - 9:39am
tags:
M&A, devices, Stryker, Pivot Medical
Merck KGaA Fourth-Quarter Profit Rises 0.7% on Cost Cuts
Bloomberg
Thursday, March 6, 2014 - 9:37am
tags:
earnings, Merck KGaA
Why Sarepta Therapeutics Inc. Might Have a Fighting Chance
Motley Fool
Wednesday, March 5, 2014 - 11:53am
tags:
Sarepta Therapeutics, eteplirsen
Sequencing pioneer Venter raises $70M to fund a new biotech to combat aging
Fierce Biotech
Wednesday, March 5, 2014 - 11:50am
tags:
Venter, gene sequencing, aging
Arrowhead Surges As Analysts Laud Hepatitis B Drug
Investors.com
Wednesday, March 5, 2014 - 11:49am
tags:
hepatitis B, Arrowhead Research, ARC-520
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com
Wednesday, March 5, 2014 - 11:46am
tags:
InterMune, Esbriet, Alexion, Soliris, Vivus, Qsymia, Regeneron, Eylea
Lilly’s Diabetes Pill Rejected by FDA Over Manufacturing
Bloomberg
Wednesday, March 5, 2014 - 11:44am
tags:
FDA, Eli Lilly, diabetes, empagliflozin, Boehringer Ingelheim
Independent Study Shows V.A.C. VeraFlo™ Therapy More Beneficial Than Traditional V.A.C.® Therapy
CP Wire
Wednesday, March 5, 2014 - 10:46am
tags:
VAC VeraFlo, devices, Kinetic Concepts
OptimizeRx - A Little Company In The Sweet Spot Of A Massive Industry
Seeking Alpha
Wednesday, March 5, 2014 - 10:13am
tags:
OptimizeRx, SampleMD, e-sampling, samples
Teva Has Appetite for ‘Game-Changing Deals,’ CFO Desheh Says
Bloomberg
Wednesday, March 5, 2014 - 10:12am
tags:
Teva Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.